CN106978445A - The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds - Google Patents
The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds Download PDFInfo
- Publication number
- CN106978445A CN106978445A CN201710437991.3A CN201710437991A CN106978445A CN 106978445 A CN106978445 A CN 106978445A CN 201710437991 A CN201710437991 A CN 201710437991A CN 106978445 A CN106978445 A CN 106978445A
- Authority
- CN
- China
- Prior art keywords
- edar
- goat
- cell
- crisper
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000283707 Capra Species 0.000 title claims abstract description 47
- 101150076559 edar gene Proteins 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 35
- 238000003209 gene knockout Methods 0.000 title claims abstract description 32
- 108091033409 CRISPR Proteins 0.000 title abstract description 12
- 210000004027 cell Anatomy 0.000 claims abstract description 73
- 239000013604 expression vector Substances 0.000 claims abstract description 18
- 108020005004 Guide RNA Proteins 0.000 claims abstract description 15
- 239000000969 carrier Substances 0.000 claims abstract description 10
- 230000001605 fetal effect Effects 0.000 claims abstract description 9
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 9
- 238000005457 optimization Methods 0.000 claims abstract description 6
- 101000920026 Homo sapiens Tumor necrosis factor receptor superfamily member EDAR Proteins 0.000 claims description 13
- 238000005516 engineering process Methods 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 238000012546 transfer Methods 0.000 claims description 7
- 230000009471 action Effects 0.000 claims description 5
- 210000000085 cashmere Anatomy 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 3
- 210000002257 embryonic structure Anatomy 0.000 claims description 3
- 210000001161 mammalian embryo Anatomy 0.000 claims description 3
- 108700024394 Exon Proteins 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000035935 pregnancy Effects 0.000 claims description 2
- 210000000287 oocyte Anatomy 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 238000011160 research Methods 0.000 abstract description 5
- 230000009261 transgenic effect Effects 0.000 abstract description 3
- 238000013459 approach Methods 0.000 abstract description 2
- 238000012214 genetic breeding Methods 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 28
- 238000012163 sequencing technique Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 235000015097 nutrients Nutrition 0.000 description 15
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 10
- 239000006285 cell suspension Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 108091027544 Subgenomic mRNA Proteins 0.000 description 9
- 230000035772 mutation Effects 0.000 description 8
- 102100030810 Tumor necrosis factor receptor superfamily member EDAR Human genes 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 238000010459 TALEN Methods 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000003113 dilution method Methods 0.000 description 3
- 238000010363 gene targeting Methods 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 101150024923 da gene Proteins 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010362 genome editing Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 231100000243 mutagenic effect Toxicity 0.000 description 2
- 230000006780 non-homologous end joining Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000010374 somatic cell nuclear transfer Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 108010040467 CRISPR-Associated Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101100332755 Mus musculus Edar gene Proteins 0.000 description 1
- 101100332756 Oryzias latipes edar gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000808793 Strigula Species 0.000 description 1
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/102—Caprine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The method that the present invention completes goat EDAR gene knockouts using CRISPER Cas9 System-mediateds, it is according to goatEDARGene order, builds two gRNA expression vectors based on CRISPER Cas9 systems, is then transferred in the fetal fibroblast of goat the CRISPER Cas9 carriers after optimization and the gRNA expression vectors built jointly, obtains the cell of goat EDAR gene knockouts.The targeting vector for the CRISPER Cas9 mediations that the present invention is built is goatEDARThe knockout of gene provides a kind of approach of simple and fast safety.This method, without reference to any riddled basins, so as to substantially increase the security of transgenic animals, has important value during cell line selection to the genetic breeding and gene functional research of goat.
Description
Technical field
The present invention relates to molecular biology and Animal Genetics field, specifically, it is related to CRISPER-Cas9 systems
The method of the goat EDAR gene knockouts of mediation.
Background technology
Modern gene editing technology includes:Zinc finger nuclease(Znic finger nuclease, ZFNs), transcriptional activation
Factor sample effector nuclease(Transcriptionactivator-like effector nuclease, TALENs)With
CRISPR-Cas9 systems.But CRISPR-Cas9 systems are sent out rapidly with its unique advantage after other two technologies occur
Exhibition is got up.CRISPR-Cas9 systems be as combined by rule cluster interval palindrome repetitive sequence and CRISPR associated protein 9s and
Into.CRISPR-Cas9 systems are needed by a sgRNA(Small guide RNA, sgRNA)As guide, target position sequence is recognized
Row, guiding Cas9 albumen completes cutting to it so that double-strand chain rupture occurs at this, can thus trigger endogenic in cell repair
The system of answering a pager's call.Endogenic repair mechanism includes two kinds of homologous recombination repair mechanism and non-homologous end joining in cell.Wherein
Homologous recombination repair mechanism is with the presence of recovery template, according to recovery template, it is possible to achieve the base of the different length of fixed point
Missing and insert, can thus be formed based on knock in and gene knockout.Non-homologous end joining repair mechanism is not accurate
Ground, in breaking part often by random insertion or deletion number of base.
Down producing goat is occupied very importantly as one of domestic animal kind of suede meat dual-purpose type in the animal husbandry of China
Position.What the improvement of down producing goat was completed by traditional breeding improvement and using modern both approach of biotechnology breeding,
Wherein it is improved by modern biotechnology in being purposeful the improveing to it of researcher, so whole improved, process
The features such as can reaching accurate, quick.
The suede matter and velour yield for improving down producing goat are the very important Breeding directions in down producing goat breeding.Hair follicle is animal
One of accessory structure of skin, it completes the growth of hair with coming off by the continuous renewal and cyclical growth of oneself.Suede
In the skin of goat, it is studied personnel with design feature sooner or later with the generation of hair follicle and is divided into primary follicle and hair follicle stimulating two
Kind.Growing for primary follicle can form wool, but growing for Secondary follicle can form cashmere.So how to improve
The change of growing of secondary lint can improve the yield of cashmere.Found at present in the research of mouse, Edar genes are controlled
Growing for primary follicle, is essential in this process, but it is in the growth and development process of Secondary follicle
Do not influence.So whether being also in this way, needing further research in the hair follicle growth growth course of down producing goat.If
EDAR knockout have impact on growing but not influenceed on growing for Secondary follicle for primary follicle in down producing goat, this
The ratio that sample just improves Secondary follicle further increases cashmere yield.
The research for knocking out goat EDAR genes using CRISPER-Cas9 systems has no report.
The content of the invention
It is an object of the invention to provide the method for the goat EDAR gene knockouts of CRISPER-Cas9 System-mediateds.
In order to realize the object of the invention, the goat EDAR gene knockouts for the CRISPER-Cas9 System-mediateds that the present invention is provided
Method, it is according to goat EDAR gene orders(Gene ID: 102179206), two are devised on its 6th exon
Individual target sequence in opposite direction, and two gRNA expression vectors based on CRISPER-Cas9 systems are built, after then optimizing
CRISPER-Cas9 carriers and the gRNA expression vectors of two above-mentioned structures be transferred to jointly in caprine fetal fibroblast cell, obtain
Obtain goat EDAR Knockout cells system.
The goat addressed in the present invention including but not limited to Aerbasi Cashmere Goats '.
Foregoing method, two gRNA target sites points are respectively positioned on 6 exons of goat EDAR genes.SgRNA1 makees
Be 5 '-GGAGAACTTCTCCGCGGGGC-3 ' with the DNA sequence dna in site, the DNA sequence dnas of sgRNA2 action sites for 5 '-
CGGCGCCACAAGGACTGCGA -3′。
Foregoing method, described CRISPER-Cas9 carriers(That is hCas9 plasmids)Nucleotide sequence such as SEQ ID
NO:Shown in 1(HCas9 plasmid maps are shown in Fig. 1);The nucleotide sequence of the EDAR-gRNA1 expression vectors such as SEQ ID NO:2
It is shown;The nucleotide sequence of the EDAR-gRNA2 expression vectors such as SEQ ID NO:Shown in 3.
The present invention also provides the cell line of the goat EDAR gene knockouts obtained according to the above method.
The present invention further provides the above method the cloned goat for preparing EDAR gene knockouts application.The application refers to
It is nuclear transfer donor cell by the cell of the goat EDAR gene knockouts, in vitro sheep egg mother cell is nuclear transfer recipient cell
Born of the same parents, by somatic cell nuclear transfer technique obtain goat clone embryos, then by clone embryos by embryo transfer technology move into by
Body goat intrauterine carries out gestation, obtains EDAR gene knockout goats.
The purpose of the present invention can also be further achieved by the following technical measures.
1)The optimization of CRISPER-Cas9 carriers;2)According to the EDAR gene orders of goat, build and be based on CRISPER-
EDAR-gRNA1 the and EDAR-gRNA2 expression vectors of Cas9 systems;3)By CRISPER-Cas9 carriers, the EDAR- of above-mentioned optimization
GRNA1 and EDAR-gRNA2 expression vectors are transfected into caprine fetal fibroblast cell jointly, pass through mouth pipette method, fluidic cell
Instrument method and dilution method screening monoclonal cell system;4)By round pcr evaluation and screening monoclonal cell system, EDAR clpp genes are obtained
The monoclonal cell system removed.
Wherein, step 3)Middle utilization dilution method picking monoclonal cell system refers to after cell transfecting is completed 24 hours, uses
With 0.25% Trypsin Induced 2-3 minutes, then terminated and digested with the DMEM/F12 nutrient solutions containing 10% hyclone, and gently
Attached cell is beaten in featheriness, disengages it from culture dish wall formation cell suspension and collection and 10mL centrifuge tubes, 1500rpm centrifugations 5
Minute.Above-mentioned cell is resuspended with PBS again, takes cell suspension to be placed on a small quantity in culture dish, under the microscope by preparing in advance
Glass rim suction pipe choose individual cells be transferred in 96 porocyte culture plates with containing 10% hyclone DMEM/F12 train
Nutrient solution is independently cultivated.
Step 3)Middle utilization flow cytometer screening monoclonal cell system refers to after cell transfecting is completed 24 hours, with use
0.25% Trypsin Induced 2-3 minutes, then digestion is terminated with the DMEM/F12 nutrient solutions containing 10% hyclone, and gently
Attached cell is blown and beaten, is disengaged it from culture dish wall formation cell suspension and collection and 10mL centrifuge tubes, 1500rpm centrifuges 5 points
Clock.Above-mentioned cell is resuspended with PBS again, then it is sorted in 96 porocyte culture plates with flow cytometer, then with containing
The DMEM/F12 nutrient solutions of 10% hyclone are independently cultivated.
Step 3)Middle utilization dilution method screening monoclonal cell system refers to after cell transfecting is completed 24 hours, with use
0.25% Trypsin Induced 2-3 minutes, then digestion is terminated with the DMEM/F12 nutrient solutions containing 10% hyclone, and gently
Attached cell is blown and beaten, is disengaged it from culture dish wall formation cell suspension and collection and 10mL centrifuge tubes, 1500rpm centrifuges 5 points
Clock.Above-mentioned cell is resuspended with the DMEM/F12 nutrient solutions containing 10% hyclone again, it is diluted to the μ L of 1 cell/100
Cell concentration.Take the μ L of cell suspension 100 to be placed in 96 porocyte culture plates after mixing independently to cultivate.
Step 4)Middle identification EDAR knocks out the PCR that monoclonal cell system mainly includes two target site areas using design amplification
The method of primer, the full sequence for expanding target sequence region by round pcr carries out sequencing analysis, purpose to the amplified fragments again
It is to determine the catastrophe of EDAR genes.
The present invention successfully obtains 89 plants altogetherEDARGene targeting monoclonal cell system is by expanding the target practice of each strain cell line
Region segments carry out sequencing analysis and find to have 62 plants of cell lineEDARGene is mutated, and mutation efficiency is 69.7%.It is right
The mutation type of each mutant clone is further analyzed, and 9 kinds of different mutation types are found that altogether, and specific mutation type is shown in Fig. 6.
The present invention has advantages below.
(One)CRISPR-Cas9 gene editings technology and conventional homologous recombination technique, TALEN technologies and ZFNs technology phases
Than gene knockout efficiency is significantly improved.
(Two)The opposite sgRNA of both direction is devised in CRISPR-Cas9 systems and completes gene knockout task, thus
The large fragment deletion of EDAR gene target position is caused, the knockout efficiency of EDAR genes is improved.
(Three)By the mediation of CRISPR-Cas9 systems, realize and be not added with any selection markers and can filter out EDAR bases
Because of the transgenic cell line of knockout, this is that traditional homologous recombination technique, TALEN technologies and ZFNs technologies can not be realized, very greatly
Degree improves the security of transgenic animals.
(Four)EDAR gene knockout goats are prepared by somatic cell nuclear transfer technique, to build ripe genetically modified animal
Research and production lay the foundation.
Brief description of the drawings
Fig. 1 is hCas9 plasmid maps in the embodiment of the present invention 1.
Fig. 2 is CRISPR-Cas9 System-mediated goat EDAR gene knockout ideographs in the embodiment of the present invention 2.
Fig. 3 is the electrophoresis result in the embodiment of the present invention 4 using Surveyor mutation detection kits detection target site;Its
In, M:200bp Ladder marker;1:Positive control;2:GRNA1 mutagenic activity situations;3:GRNA2 catastrophes.
Fig. 4 is the bimodal figure of EDAR gene knockout total cells target area sequence in the embodiment of the present invention 5.
Fig. 5 is EDAR gene knockout monoclonal cell figures in the embodiment of the present invention 5.
Fig. 6 is each monoclonal cell EDAR gene knockout type maps in the embodiment of the present invention 6.Wherein strigula represents base
Missing, square frame represents to insert base.
Embodiment
Following examples are used to illustrate the present invention, but are not limited to the scope of the present invention.Unless otherwise specified, embodiment
According to conventional laboratory conditions, such as Sambrook equimoleculars Cloning: A Laboratory Manual(Sambrook J & Russell DW,
Molecular cloning: a laboratory manual, 2001), or according to the condition of manufacturer's specification suggestion.
Examining order is completed by Hua Da gene in following examples.
The optimization of the CRISPER-Cas9 carriers of embodiment 1.
CRISPR-Cas9 expression vectors purchased from Beijing Central Plains company are optimized, the CRISPER-Cas9 of optimization is carried
Body(That is hCas9 plasmids)Nucleotide sequence such as SEQ ID NO:Shown in 1, hCas9 plasmid maps are shown in Fig. 1.
The structure of the gRNA expression vectors of embodiment 2.
According to the EDAR gene orders of goat(Gene ID: 102179206), for EDAR the 6th exon sequence
SgRNA sequences are designed, and build the gRNA expression vectors based on CRISPER-Cas9 systems.GRNA expression vectors include 4 parts:
U6 promoters, target sequence, gRNA skeletons and termination signal.Based on CRISPR-Cas9 System-mediated goat EDAR gene knockout moulds
Formula figure is shown in Fig. 2.Wherein, the DNA sequence dna of sgRNA action sites is as follows:sgRNA1:5 '-GGAGAACTTCTCCGCGGGGC-3 ',
sgRNA2:5′-CGGCGCCACAAGGACTGCGA-3′.Using biological software according to sgRNA action sites(SgRNA1 target position
Point and sgRNA2 target sites)SgRNA sequences are separately designed, are cloned on gRNA expression vectors, conversion Escherichia coli Trans-
110, picking single bacterium colony after coated plate carries out bacterium solution PCR, through electrophoresis and sequencing identification, and correct single bacterium colony is sequenced and is inoculated in containing Amp
LB culture mediums in, 37 DEG C, 220rpm Guo Ye Oscillating bacterium, extract plasmid it is standby.EDAR-gRNA1 carriers and EDAR-gRNA2 carriers
Nucleotide sequence such as SEQ ID NO:2 and SEQ ID NO:Shown in 3.
The electroporation of embodiment 3 transfects caprine fetal fibroblast cell.
Defrosting caprine fetal fibroblast cell is inoculated in 100mm culture dishes, be placed in 37 DEG C, 5%CO2,100% relative humidity
Incubator in the DMEM/F12 nutrient solution cultures containing 10% hyclone.Treat that its growth reaches 90% cell confluency degree
When use PBS cell, then with 0.25% Trypsin Induced 2-3 minutes, then with the DMEM/ containing 10% hyclone
F12 nutrient solutions terminate digestion, and gently blow and beat attached cell, disengage it from culture dish wall formation cell suspension and collection and 10mL
In centrifuge tube, 1500rpm is centrifuged 5 minutes.Centrifugation terminate after remove supernatant nutrient solution, add PBS be resuspended cell, then with
1500rpm centrifuges 5 minutes cleaning cell precipitations twice.Finally cleaned herein after cell precipitation with Opti-MEM nutrient solutions, with suitable
Amount Opti-MEM nutrient solutions are resuspended cell and reach 1 × 105Individual/μ L cell concentrations.Above-mentioned 90 μ L cell suspension is taken to add 10 μ g
Plasmid(Cas9:gRNA=1:19), totally 10 μ L.It is careful after well mixed to add above-mentioned mixed cell suspension in electric shock cup,
Avoid producing bubble during this, in order to avoid influence transfection.Electric shock cup is put into the electric revolving cup chamber of NEPA21 electroporations, according to
225V/2.5ms electrotransfection condition completes electricity according to the operation instructions of electroporation and turns experiment.Containing with preheating after electricity turns
The DMEM/F12 nutrient solutions of 10% hyclone are resuspended cell and are inoculated in the DMEM/F12 cultures containing 10% hyclone
Cultivated in the culture dish of liquid.
SgRNA Activity determination in the CRISPER-Cas9 systems of embodiment 4.
Using the caprine fetal fibroblast cell of wild type as control, by EDAR-gRNA1+ Cas9 and EDAR-gRNA2+
Cas9 plasmids transfect caprine fetal fibroblast cell by electroporation.By cultivating after enrichment target practice cell, this is extracted respectively
The genomic DNA of two groups of cells and wild-type cell.Then it is anti-by PCR using genomic DNA obtained above as template
Should, expand the target position sequence of EDAR genes.Specific PCR reactions primer is as follows:edar-6exonF:
GTGGTGGTCGTCGTGGTGATGC, edar-6exonR:CTGCTCAGCCTTCCTTATGGTC.PCR reaction total systems are 20 μ L
μL:0.2 μ L, 10 × La PCR Buffer of La Taq, II 2 μ L, dNTP Mixture 3.2 μ L, the μ L of DNA 0.4, upper,
Anti-sense primer(100 mmol•L-1)Each 0.8 μ L, the μ L of aqua sterilisa 12.6.Expand the PCR reaction conditions of EDAR gene target position sequences:
94 DEG C of min of pre-degeneration 10;94 DEG C of 30 sec of denaturation, 63 DEG C of annealing 45 sec, 72 DEG C of 1 min of extension, 35 circulations;72℃
10 min, 16 DEG C of 1 h.After amplification terminates, by the size of 1.5% agarose gel electrophoresis testing goal band, and return
Receive and purified after purpose band adhesive tape.The fragment wild-type fragment respectively with two experimental groups is carried out by the method progressively annealed again
DNA hybridization.Specifically DNA hybridization reaction system is:DNA30µL(120ng/µL), the μ L of 10 × La PCR Buffer II 3,.It is miscellaneous
Friendship program is shown in Table 1.
The DNA hybridization program of table 1
Obtain after hybrid dna, mutagenic activity is detected by using Surveyor mutation detection kits.It is prominent according to Surveyor
Become the operation instructions of detection kit to complete experiment, specific reaction system is shown in Table 2.
The Surveyor abrupt climatic change systems of table 2
After reaction system configuration is finished, it is placed in 42 DEG C and reacts 1 hour, finally by after the Stop Solution for entering 2.5 μ L, incite somebody to action
Above-mentioned reaction solution detects the size of DNA fragmentation by 2% agarose gel electrophoresis.Testing result is shown in that Fig. 3, two kinds of sgRNA are respectively provided with
Activity, can mediate Cas9 to cut target position sequence.
The screening of the monoclonal cell system of embodiment 5.
The present embodiment is intended to screeningEDARGene knockout monoclonal cell system.
EDAR-gRNA1+EDAR-gRNA2+Cas9 plasmids are transfected into caprine fetal fibroblast cell by electroporation.Carefully
After dysuria with lower abdominal colic contaminates 24 hours, with 0.25% Trypsin Induced 2-3 minute, then with the DMEM/F12 trainings containing 10% hyclone
Nutrient solution terminates digestion, and gently blows and beats attached cell, disengages it from culture dish wall formation cell suspension and collection is centrifuged with 10mL
Guan Zhong, 1500rpm are centrifuged 5 minutes.Above-mentioned cell is resuspended with PBS again, EDAR gene knockout total cells are obtained, and take part cell
Genomic DNA is extracted, PCR amplification target practice regional sequences carry out sequencing analysis.Pass through three kinds of method picking monoclonal cells again.Side
Method one, using selected by flow cytometry apoptosis into unicellular, 96 holes containing cell culture fluid are inoculated in after pre-balance by unicellular
In Tissue Culture Plate.Method two, using mouth suction pipe picking monoclonal cell system, be drawn into glass tube guarantee can make it is single thin
The suitable diameter mouthful suction pipe that born of the same parents pass through, under the microscope sterile working is inoculated in after pre-balance containing thin respectively by unicellular
In 96 porocyte culture plates of born of the same parents' nutrient solution, cell culture is carried out.Method three, with the DMEM/F12 containing 10% hyclone
Above-mentioned cell is resuspended in nutrient solution, the cell concentration for making it be diluted to the μ L of 1 cell/100.The μ L of cell suspension 100 are taken after mixing
It is placed in 96 porocyte culture plates and independently cultivates.At the 10th day, observe under the microscope, by the higher cell clone of degree of converging
It is passaged in two holes of 24 orifice plates and cultivates, liquid is changed to cell progress in 24h after passage, when the cell clone degree of converging of passage reaches
During to more than 90%, digested with 0.25% trypsase, the cell in a hole is added into 1ml frozen stock solutions(0.1mLDMSO+0.9mL
Serum)Freeze, another hole cell extraction genome.
It is bimodal existing by occurring to the discovery of EDAR gene knockout total cell target practice regional sequences sequencing analysis behind target position
As(See Fig. 4), so assert the success of EDAR gene knockouts.Expand each EDAR gene targetings monoclonal cell by unicellular culture
Strain(See Fig. 5).
The identification of the monoclonal cell system of embodiment 6.
Using the genomic DNA of each monoclonal cell system as template, reacted by PCR, expand the target position sequence of EDAR genes
Row.Specific PCR reacts primer:edar-6exonF:GTGGTGGTCGTCGTGGTGATGC, edar-6exonR:
CTGCTCAGCCTTCCTTATGGTC.PCR reaction total systems are 20 μ L μ L:μ L, the 10 × La PCR Buffer II of La Taq 0.2
2 μ L, dNTP Mixture 3.2 μ L, the μ L of DNA 0.4, upstream and downstream primer(100 mmol•L-1)Each 0.8 μ L, aqua sterilisa
12.6µL.Expand the PCR reaction conditions of EDAR gene target position sequences:94 DEG C of min of pre-degeneration 10;94 DEG C of 30 sec of denaturation, 63
DEG C annealing 45 sec, 72 DEG C extension 1 min, 35 circulation;72 DEG C of 10 min, 16 DEG C of 1 h.After amplification terminates, by what is obtained
PCR primer is sent in the analysis of Hua Da gene sequencing.Find that each EDAR gene targetings monoclonal cell strain has 9 kinds by sequencing analysis
Mutation type, specific mutation type is shown in Fig. 6.
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, belong to the scope of protection of present invention without departing from theon the basis of the spirit of the present invention.
SEQUENCE LISTING
<110>University of the Inner Mongol
<120>The method of the goat EDAR gene knockouts of CRISPER-Cas9 System-mediateds
<130>The method of the goat EDAR gene knockouts of CRISPER-Cas9 System-mediateds
<160> 17
<170> PatentIn version 3.3
<210> 1
<211> 9553
<212> DNA
<213>HCas9 plasmids
<400> 1
atggtggtgt cgaagtactt gaaggctgca ggcgcgccca agttggtcag agtaaacaag 60
tggataatgt tttctgcctg ctccctgatg ggcttatccc tgtgcttatt gtaagcagaa 120
agcaccttat cgaggttagc gtcggcgagg atcactcttt tggagaattc gcttatttgc 180
tcgatgatct catcaaggta gtgtttgtgt tgttccacga acagctgctt ctgctcatta 240
tcttcgggag accctttgag cttttcatag tggctggcca gatacaagaa attaacgtat 300
ttagagggca gtgccagctc gttacctttc tgcagctcgc ccgcactagc gagcattcgt 360
ttccggccgt tttcaagctc aaagagagag tacttgggaa gcttaatgat gaggtctttt 420
ttgacctctt tatatccttt cgcctcgaga aagtcgatgg ggtttttttc gaagcttgat 480
cgctccatga ttgtgatgcc cagcagttcc ttgacgcttt tgagtttttt agacttccct 540
ttctccactt tggccacaac cagtacactg taagcgactg taggagaatc gaatccgccg 600
tatttcttgg ggtcccaatc ttttttgcgt gcgatcagct tgtcgctgtt ccttttcggg 660
aggatacttt ccttggagaa gcctccggtc tgtacttcgg tctttttaac gatgttcacc 720
tgcggcatgg acaggacctt ccggactgtc gcgaaatccc tacccttgtc ccacacgatt 780
tctcctgttt ctccgtttgt ttcgataagt ggtcgcttcc gaatctctcc attggccagt 840
gtaatctcgg tcttgaaaaa attcataata ttgctgtaaa agaagtactt agcggtggcc 900
ttgcctattt cctgctcaga ctttgcgatc attttcctaa catcgtacac tttatagtct 960
ccgtaaacaa attcagattc aagcttggga tattttttga taagtgcagt gcctaccact 1020
gcattcaggt aggcatcatg cgcatggtgg taattgttga tctctctcac cttataaaac 1080
tgaaagtcct ttctgaaatc tgagaccagc ttagacttca gagtaataac tttcacctct 1140
cgaatcagtt tgtcattttc atcgtacttg gtgttcatgc gtgaatcgag aatttgggcc 1200
acgtgcttgg tgatctggcg tgtctcaaca agctgccttt tgatgaagcc ggctttatcc 1260
aactcagaca ggccacctcg ttcagcctta gtcagattat cgaacttccg ttgtgtgatc 1320
agtttggcgt tcagcagctg ccgccaataa tttttcattt tcttgacaac ttcttctgag 1380
gggacgttat cactcttccc tctattttta tcggatcttg tcaacacttt attatcaata 1440
gaatcatctt tgagaaaaga ctggggcacg atatgatcca cgtcgtagtc ggagagccga 1500
ttgatgtcca gttcctgatc cacgtacatg tccctgccgt tctgcaggta gtacaggtag 1560
agcttctcat tctgaagctg ggtgttttca actgggtgtt ccttaaggat ttgggacccc 1620
agttctttta taccctcttc aatcctcttc atcctttccc tactgttctt ctgtcccttc 1680
tgggtagttt ggttctctcg ggccatctcg ataacgatat tctcgggctt atgccttccc 1740
attactttga cgagttcatc cacgacctta acggtctgca gtattccctt tttgatagct 1800
gggctacctg caagattagc gatgtgctcg tgaagactgt ccccctggcc agaaacttgt 1860
gctttctgga tgtcctcctt aaaggtgaga gagtcatcat ggatcaactg catgaagttc 1920
cggttggcaa atccatcgga cttaagaaaa tccaggattg tctttccact ctgcttgtct 1980
cggatcccat tgatcagttt tcttgacagc cgcccccatc ctgtatatcg gcgcctcttg 2040
agctgtttca tgactttgtc gtcgaagaga tgagcgtaag ttttcaagcg ttcttcaatc 2100
atctccctat cttcaaacaa cgtaagggtg aggacaatgt cctcaagaat gtcctcgttc 2160
tcctcattgt ccaggaagtc cttgtcttta atgattttca ggagatcgtg atacgttccc 2220
agggatgcgt tgaagcgatc ctccactccg ctgatttcaa cagagtcgaa acattcaatc 2280
tttttgaaat agtcttcttt gagctgtttc acggtaactt tccggttcgt cttgaagagg 2340
aggtccacga tagctttctt ctgctctcca gacaggaatg ctggctttct catcccttct 2400
gtgacgtatt tgaccttggt gagctcgtta taaactgtga agtactcgta cagcagagag 2460
tgtttaggaa gcaccttttc gttaggcaga tttttatcaa agttagtcat cctttcgatg 2520
aaggactggg cagaggcccc cttatccacg acttcctcga agttccaggg agtgatggtc 2580
tcttctgatt tgcgagtcat ccacgcgaat ctggaatttc cccgggcgag ggggcctaca 2640
tagtagggta tccgaaatgt gaggattttc tcaatctttt ccctgttatc tttcaaaaag 2700
gggtagaaat cctcttgccg cctgaggata gcgtgcagtt cgcccaggtg aatctggtgg 2760
gggatgcttc cattgtcgaa agtgcgctgt ttgcgcaaca gatcttctct gttaagcttt 2820
accagcagct cctcggtgcc gtccattttt tccaagatgg gcttaataaa tttgtaaaat 2880
tcctcctggc ttgctccgcc gtcaatgtat ccggcgtagc catttttaga ctgatcgaag 2940
aaaatttcct tgtacttctc aggcagttgc tgtctgacaa gggccttcag caaagtcaag 3000
tcttggtggt gctcatcata gcgcttgatc atactagcgc tcagcggagc tttggtgatc 3060
tccgtgttca ctcgcagaat atcactcagc agaatggcgt ctgacaggtt ctttgccgcc 3120
aaaaaaaggt ctgcgtactg gtcgccgatc tgggccagca gattgtcgag atcatcatcg 3180
taggtgtctt tgctcagttg aagcttggca tcttcggcca ggtcgaagtt agatttaaag 3240
ttgggggtca gcccgagtga cagggcgata agattaccaa acaggccgtt cttcttctcc 3300
ccagggagct gtgcgatgag gttttcgagc cgccgggatt tggacagcct agcgctcagg 3360
attgctttgg cgtcaactcc ggatgcgttg atcgggttct cttcgaaaag ctgattgtaa 3420
gtctgaacca gttggataaa gagtttgtcg acatcgctgt tgtctgggtt caggtccccc 3480
tcgatgagga agtgtccccg aaatttgatc atatgcgcca gcgcgagata gatcaaccgc 3540
aagtcagcct tatcagtact gtctacaagc ttcttcctca gatgatatat ggttgggtac 3600
ttttcatggt acgccacctc gtccacgata ttgccaaaga ttgggtggcg ctcgtgcttt 3660
ttatcctcct ccaccaaaaa ggactcctcc agcctatgga agaaagagtc atccacctta 3720
gccatctcat tactaaagat ctcctgcagg tagcagatcc gattctttct gcgggtatat 3780
ctgcgccgtg ctgttctttt gagccgcgtg gcttcggccg tctccccgga gtcgaacagg 3840
agggcgccaa tgaggttctt ctttatgctg tggcgatcgg tattgcccag aactttgaat 3900
tttttgctcg gcaccttgta ctcgtccgta atgacggccc agccgacgct gtttgtgccg 3960
atatcgagcc caatggagta cttcttgtcc atggtggcaa gggttcgatc ctctagagtc 4020
cggaggctgg atcggtcccg gtgtcttcta tggaggtcaa aacagcgtgg atggcgtctc 4080
caggcgatct gacggttcac taaacgagct ctgcttatat agacctccca ccgtacacgc 4140
ctaccgccca tttgcgtcaa tggggcggag ttgttacgac attttggaaa gtcccgttga 4200
ttttggtgcc aaaacaaact cccattgacg tcaatggggt ggagacttgg aaatccccgt 4260
gagtcaaacc gctatccacg cccattgatg tactgccaaa accgcatcac catggtaata 4320
gcgatgacta atacgtagat gtactgccaa gtaggaaagt cccataaggt catgtactgg 4380
gcataatgcc aggcgggcca tttaccgtca ttgacgtcaa tagggggcgt acttggcata 4440
tgatacactt gatgtactgc caagtgggca gtttaccgta aatactccac ccattgacgt 4500
caatggaaag tccctattgg cgttactatg ggaacatacg tcattattga cgtcaatggg 4560
cgggggtcgt tgggcggtca gccaggcggg ccatttaccg taagttatgt aacgcggaac 4620
tccatatatg ggctatgaac taatgacccc gtaattgatt actattaata actagtcaat 4680
aatcaatgtc aacgcgtata tctggcccgt acatcgcgaa gcagcgcaaa acgcctaacc 4740
ctaagcagat tcttcatgca attgtcggtc aagccttgcc ttgttgtagc ttaaattttg 4800
ctcgcgcact actcagcgac ctccaacaca caagcaggga gcagatactg gcttaactat 4860
gcggcatcag agcagattgt actgagagtg caccataggg gatcgggaga tctcccgatc 4920
cgtcgacgtc aggtggcact tttcggggaa atgtgcgcgg aacccctatt tgtttatttt 4980
tctaaataca ttcaaatatg tatccgctca tgagacaata accctgataa atgcttcaat 5040
aatattgaaa aaggaagagt atgagtattc aacatttccg tgtcgccctt attccctttt 5100
ttgcggcatt ttgccttcct gtttttgctc acccagaaac gctggtgaaa gtaaaagatg 5160
ctgaagatca gttgggtgca cgagtgggtt acatcgaact ggatctcaac agcggtaaga 5220
tccttgagag ttttcgcccc gaagaacgtt ttccaatgat gagcactttt aaagttctgc 5280
tatgtggcgc ggtattatcc cgtattgacg ccgggcaaga gcaactcggt cgccgcatac 5340
actattctca gaatgacttg gttgagtact caccagtcac agaaaagcat cttacggatg 5400
gcatgacagt aagagaatta tgcagtgctg ccataaccat gagtgataac actgcggcca 5460
acttacttct gacaacgatc ggaggaccga aggagctaac cgcttttttg cacaacatgg 5520
gggatcatgt aactcgcctt gatcgttggg aaccggagct gaatgaagcc ataccaaacg 5580
acgagcgtga caccacgatg cctgtagcaa tggcaacaac gttgcgcaaa ctattaactg 5640
gcgaactact tactctagct tcccggcaac aattaataga ctggatggag gcggataaag 5700
ttgcaggacc acttctgcgc tcggcccttc cggctggctg gtttattgct gataaatctg 5760
gagccggtga gcgtgggtct cgcggtatca ttgcagcact ggggccagat ggtaagccct 5820
cccgtatcgt agttatctac acgacgggga gtcaggcaac tatggatgaa cgaaatagac 5880
agatcgctga gataggtgcc tcactgatta agcattggta actgtcagac caagtttact 5940
catatatact ttagattgat ttaaaacttc atttttaatt taaaaggatc taggtgaaga 6000
tcctttttga taatctcatg accaaaatcc cttaacgtga gttttcgttc cactgagcgt 6060
cagaccccgt agaaaagatc aaaggatctt cttgagatcc tttttttctg cgcgtaatct 6120
gctgcttgca aacaaaaaaa ccaccgctac cagcggtggt ttgtttgccg gatcaagagc 6180
taccaactct ttttccgaag gtaactggct tcagcagagc gcagatacca aatactgttc 6240
ttctagtgta gccgtagtta ggccaccact tcaagaactc tgtagcaccg cctacatacc 6300
tcgctctgct aatcctgtta ccagtggctg ctgccagtgg cgataagtcg tgtcttaccg 6360
ggttggactc aagacgatag ttaccggata aggcgcagcg gtcgggctga acggggggtt 6420
cgtgcacaca gcccagcttg gagcgaacga cctacaccga actgagatac ctacagcgtg 6480
agctatgaga aagcgccacg cttcccgaag ggagaaaggc ggacaggtat ccggtaagcg 6540
gcagggtcgg aacaggagag cgcacgaggg agcttccagg gggaaacgcc tggtatcttt 6600
atagtcctgt cgggtttcgc cacctctgac ttgagcgtcg atttttgtga tgctcgtcag 6660
gggggcggag cctatggaaa aacgccagca acgcggcctt tttacggttc ctggcctttt 6720
gctggccttt tgctcacatg ttctttcctg cgttatcccc tgattctgtg gataaccgta 6780
ttaccgcctt tgagtgagct gataccgctc gccgcagccg aacgaccgag cgcagcgagt 6840
cagtgagcga ggaagcggaa gagcgcccaa tacgcaaacc gcctctcccc gcgcgttggc 6900
cgattcatta atgcagctgg cacgacaggt ttcccgactg gaaagcgggc agtgagcgca 6960
acgcaattaa tgtgagttag ctcactcatt aggcacccca ggctttacac tttatgcttc 7020
cggctcgtat gttgtgtgga attgtgagcg gataacaatt tcacacagga aacagctatg 7080
accatgatta cgccaagctc tagctagagg tcgacggtat acagacatga taagatacat 7140
tgatgagttt ggacaaacca caactagaat gcagtgaaaa aaatgcttta tttgtgaaat 7200
ttgtgatgct attgctttat ttgtaaccat tataagctgc aataaacaag ttggggtggg 7260
cgaagaactc cagcatgaga tccccgcgct ggaggatcat ccagccggcg tcccggaaaa 7320
cgattccgaa gcccaacctt tcatagaagg cggcggtgga atcgaaatct cgtgatggca 7380
ggttgggcgt cgcttggtcg gtcatttcgc gaaccccaga gtcccgctca gaagaactcg 7440
tcaagaaggc gatagaaggc gatgcgctgc gaatcgggag cggcgatacc gtaaagcacg 7500
aggaagcggt cagcccattc gccgccaagc tcttcagcaa tatcacgggt agccaacgct 7560
atgtcctgat agcggtccgc cacacccagc cggccacagt cgatgaatcc agaaaagcgg 7620
ccattttcca ccatgatatt cggcaagcag gcatcgccat gggtcacgac gagatcctcg 7680
ccgtcgggca tgcgcgcctt gagcctggcg aacagttcgg ctggcgcgag cccctgatgc 7740
tcttcgtcca gatcatcctg atcgacaaga ccggcttcca tccgagtacg tgctcgctcg 7800
atgcgatgtt tcgcttggtg gtcgaatggg caggtagccg gatcaagcgt atgcagccgc 7860
cgcattgcat cagccatgat ggatactttc tcggcaggag caaggtgaga tgacaggaga 7920
tcctgccccg gcacttcgcc caatagcagc cagtcccttc ccgcttcagt gacaacgtcg 7980
agcacagctg cgcaaggaac gcccgtcgtg gccagccacg atagccgcgc tgcctcgtcc 8040
tgcagttcat tcagggcacc ggacaggtcg gtcttgacaa aaagaaccgg gcgcccctgc 8100
gctgacagcc ggaacacggc ggcatcagag cagccgattg tctgttgtgc ccagtcatag 8160
ccgaatagcc tctccaccca agcggccgga gaacctgcgt gcaatccatc ttgttcaatc 8220
atgcgaaacg atcctcatcc tgtctcttga tcagatccga aaatggatat acaagctccc 8280
gggagctttt tgcaaaagcc taggcctcca aaaaagcctc ctcactactt ctggaatagc 8340
tcagaggcag aggcggcctc ggcctctgca taaataaaaa aaattagtca gccatggggc 8400
ggagaatggg cggaactggg cggagttagg ggcgggatgg gcggagttag gggcgggact 8460
atggttgctg actaattgag atgcatgctt tgcatacttc tgcctgctgg ggagcctggg 8520
gactttccac acctggttgc tgactaattg agatgcatgc tttgcatact tctgcctgct 8580
ggggagcctg gggactttcc acaccctaac tgacacacat tccacagaat taattcgcgt 8640
taaatttttg ttaaatcagc tcatttttta accaataggc cgaaatcggc aaaatccctt 8700
ataaatcaaa agaatagacc gagatagggt tgagtgttgt tccagtttgg aacaagagtc 8760
cactattaaa gaacgtggac tccaacgtca aagggcgaaa aaccgtctat cagggcgatg 8820
gcccactacg tgaaccatca ccctaatcaa gttttttggg gtcgaggtgc cgtaaagcac 8880
taaatcggaa ccctaaaggg agcccccgat ttagagcttg acggggaaag ccggcgaacg 8940
tggcgagaaa ggaagggaag aaagcgaaag gagcgggcgc tagggcgctg gcaagtgtag 9000
cggtcacgct gcgcgtaacc accacacccg ccgcgcttaa tgcgccgcta cagggcgcgt 9060
ggggataccc cctagagccc cagctgcgca gatctgctat ggcagggcct gccgccccga 9120
cgttggctgc gagccctggg ccttcacccg aacttggggg gtggggtggg gaaaaggaag 9180
aaacgcgggc gtattggccc caatggggtc tcggtggggt atcgacagag tgccagccct 9240
gggaccgaac cccgcgttta tgaacaaacg acccaacacc cgtgcgtttt attctgtctt 9300
tttattgccg tcatagcgcg ggttccttcc ggtattgtct ccttccgtgt ttcagttagc 9360
ctcccccgtt taaactcatt actaaccggt agggatcgaa ccctttcaca ccttcctctt 9420
cttcttgggg tcagccctgc tgtctccacc gagctgagag aggtcgattc ttgtttcata 9480
gagccccgta attgactgat gaatcagtgt ggcgtccagg acctcctttg tagaggtgta 9540
ccgctttctg tct 9553
<210> 2
<211> 455
<212> DNA
<213>EDAR-gRNA1 plasmids
<400> 2
tgtacaaaaa agcaggcttt aaaggaacca attcagtcga ctggatccgg taccaaggtc 60
gggcaggaag agggcctatt tcccatgatt ccttcatatt tgcatatacg atacaaggct 120
gttagagaga taattagaat taatttgact gtaaacacaa agatattagt acaaaatacg 180
tgacgtagaa agtaataatt tcttgggtag tttgcagttt taaaattatg ttttaaaatg 240
gactatcata tgcttaccgt aacttgaaag tatttcgatt tcttggcttt atatatcttg 300
tggaaaggac gaaacaccgg agaacttctc cgcggggcgt tttagagcta gaaatagcaa 360
gttaaaataa ggctagtccg ttatcaactt gaaaaagtgg caccgagtcg gtgctttttt 420
tctagaccca gctttcttgt acaaagttgg catta 455
<210> 3
<211> 455
<212> DNA
<213>EDAR-gRNA2 plasmids
<220>
<221> misc_feature
<222> (319)..(338)
<223> n is a, c, g, or t
<400> 3
tgtacaaaaa agcaggcttt aaaggaacca attcagtcga ctggatccgg taccaaggtc 60
gggcaggaag agggcctatt tcccatgatt ccttcatatt tgcatatacg atacaaggct 120
gttagagaga taattagaat taatttgact gtaaacacaa agatattagt acaaaatacg 180
tgacgtagaa agtaataatt tcttgggtag tttgcagttt taaaattatg ttttaaaatg 240
gactatcata tgcttaccgt aacttgaaag tatttcgatt tcttggcttt atatatcttg 300
tggaaaggac gaaacaccnn nnnnnnnnnn nnnnnnnngt tttagagcta gaaatagcaa 360
gttaaaataa ggctagtccg ttatcaactt gaaaaagtgg caccgagtcg gtgctttttt 420
tctagaccca gctttcttgt acaaagttgg catta 455
<210> 4
<211> 20
<212> DNA
<213>SgRNA1 target sites
<400> 4
ggagaacttc tccgcggggc 20
<210> 5
<211> 20
<212> DNA
<213>SgRNA2 target sites
<400> 5
cggcgccaca aggactgcga 20
<210> 6
<211> 22
<212> DNA
<213>Artificial sequence
<400> 6
gtggtggtcg tcgtggtgat gc 22
<210> 7
<211> 22
<212> DNA
<213>Artificial sequence
<400> 7
ctgctcagcc ttccttatgg tc 22
<210> 8
<211> 661
<212> DNA
<213>Wild type sequencing result
<400> 8
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gttccctgcc ccgcggagaa 120
gttctccaag ggcggctacc agatctgccg gcgccacaag gactgcgagg gcttcttccg 180
cgccacggtg ctgaccccgg gggacacaga gcgcgacgct gagtgtgggc cctgcttgcc 240
tgggtgagct ccgtgccgcc ctgcccacgt acccctcccg ggcatgggtc ctgctgggag 300
gagagtctca catctccagc tccgggagag gagggaagag gggcacaggt ctcctggtgg 360
gggtcccacc accttccacc cgcagggcag cccacctggg ctccatgtct gtgtccctaa 420
gtggacctca tcataatagc atctctgacc acccaaatca agcagatgtg ttgaatactt 480
aaaaggagac aacacatgtg gagtgaggaa agaaaaaaac aaggtatttt ttgtattttt 540
agtattctgg aaaaaaactg agggtgaaaa gctaccaata gaaatatttg taatcaaagc 600
tatggtgttt ccagtagtca tgtatggata tgagaggtgg accataagga aggctgagca 660
g 661
<210> 9
<211> 625
<212> DNA
<213>Type-1 sequencing results
<400> 9
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gttccctgcc ccgcggagaa 120
gttctccaag ggcggcttct tccgcgccac ggtgctgacc ccgggggaca cagagcgcga 180
cgctgagtgt gggccctgct tgcctgggtg agctccgtgc cgccctgccc acgtacccct 240
cccgggcatg ggtcctgctg ggaggagagt ctcacatctc cagctccggg agaggaggga 300
agaggggcac aggtctcctg gtgggggtcc caccaccttc cacccgcagg gcagcccacc 360
tgggctccat gtctgtgtcc ctaagtggac ctcatcataa tagcatctct gaccacccaa 420
atcaagcaga tgtgttgaat acttaaaagg agacaacaca tgtggagtga ggaaagaaaa 480
aaacaaggta ttttttgtat ttttagtatt ctggaaaaaa actgagggtg aaaagctacc 540
aatagaaata tttgtaatca aagctatggt gtttccagta gtcatgtatg gatatgagag 600
gtggaccata aggaaggctg agcag 625
<210> 10
<211> 606
<212> DNA
<213>Type-2 sequencing results
<400> 10
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gttccctgcc cgagggcttc 120
ttccgcgcca cggtgctgac cccgggggac acagagcgcg acgctgagtg tgggccctgc 180
ttgcctgggt gagctccgtg ccgccctgcc cacgtacccc tcccgggcat gggtcctgct 240
gggaggagag tctcacatct ccagctccgg gagaggaggg aagaggggca caggtctcct 300
ggtgggggtc ccaccacctt ccacccgcag ggcagcccac ctgggctcca tgtctgtgtc 360
cctaagtgga cctcatcata atagcatctc tgaccaccca aatcaagcag atgtgttgaa 420
tacttaaaag gagacaacac atgtggagtg aggaaagaaa aaaacaaggt attttttgta 480
tttttagtat tctggaaaaa aactgagggt gaaaagctac caatagaaat atttgtaatc 540
aaagctatgg tgtttccagt agtcatgtat ggatatgaga ggtggaccat aaggaaggct 600
gagcag 606
<210> 11
<211> 608
<212> DNA
<213>Type-3 sequencing results
<400> 11
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gttccctgcc tgcgagggct 120
tcttccgcgc cacggtgctg accccggggg acacagagcg cgacgctgag tgtgggccct 180
gcttgcctgg gtgagctccg tgccgccctg cccacgtacc cctcccgggc atgggtcctg 240
ctgggaggag agtctcacat ctccagctcc gggagaggag ggaagagggg cacaggtctc 300
ctggtggggg tcccaccacc ttccacccgc agggcagccc acctgggctc catgtctgtg 360
tccctaagtg gacctcatca taatagcatc tctgaccacc caaatcaagc agatgtgttg 420
aatacttaaa aggagacaac acatgtggag tgaggaaaga aaaaaacaag gtattttttg 480
tatttttagt attctggaaa aaaactgagg gtgaaaagct accaatagaa atatttgtaa 540
tcaaagctat ggtgtttcca gtagtcatgt atggatatga gaggtggacc ataaggaagg 600
ctgagcag 608
<210> 12
<211> 607
<212> DNA
<213>Type-4 sequencing results
<400> 12
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gtttttcttt gcgagggctt 120
cttccgcgcc acggtgctga ccccggggga cacagagcgc gacgctgagt gtgggccctg 180
cttgcctggg tgagctccgt gccgccctgc ccacgtaccc ctcccgggca tgggtcctgc 240
tgggaggaga gtctcacatc tccagctccg ggagaggagg gaagaggggc acaggtctcc 300
tggtgggggt cccaccacct tccacccgca gggcagccca cctgggctcc atgtctgtgt 360
ccctaagtgg acctcatcat aatagcatct ctgaccaccc aaatcaagca gatgtgttga 420
atacttaaaa ggagacaaca catgtggagt gaggaaagaa aaaaacaagg tattttttgt 480
atttttagta ttctggaaaa aaactgaggg tgaaaagcta ccaatagaaa tatttgtaat 540
caaagctatg gtgtttccag tagtcatgta tggatatgag aggtggacca taaggaaggc 600
tgagcag 607
<210> 13
<211> 605
<212> DNA
<213>Type-5 sequencing results
<400> 13
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gttccctgcc gagggcttct 120
tccgcgccac ggtgctgacc ccgggggaca cagagcgcga cgctgagtgt gggccctgct 180
tgcctgggtg agctccgtgc cgccctgccc acgtacccct cccgggcatg ggtcctgctg 240
ggaggagagt ctcacatctc cagctccggg agaggaggga agaggggcac aggtctcctg 300
gtgggggtcc caccaccttc cacccgcagg gcagcccacc tgggctccat gtctgtgtcc 360
ctaagtggac ctcatcataa tagcatctct gaccacccaa atcaagcaga tgtgttgaat 420
acttaaaagg agacaacaca tgtggagtga ggaaagaaaa aaacaaggta ttttttgtat 480
ttttagtatt ctggaaaaaa actgagggtg aaaagctacc aatagaaata tttgtaatca 540
aagctatggt gtttccagta gtcatgtatg gatatgagag gtggaccata aggaaggctg 600
agcag 605
<210> 14
<211> 598
<212> DNA
<213>Type-6 sequencing results
<400> 14
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gtcgagggct tcttccgcgc 120
cacggtgctg accccggggg acacagagcg cgacgctgag tgtgggccct gcttgcctgg 180
gtgagctccg tgccgccctg cccacgtacc cctcccgggc atgggtcctg ctgggaggag 240
agtctcacat ctccagctcc gggagaggag ggaagagggg cacaggtctc ctggtggggg 300
tcccaccacc ttccacccgc agggcagccc acctgggctc catgtctgtg tccctaagtg 360
gacctcatca taatagcatc tctgaccacc caaatcaagc agatgtgttg aatacttaaa 420
aggagacaac acatgtggag tgaggaaaga aaaaaacaag gtattttttg tatttttagt 480
attctggaaa aaaactgagg gtgaaaagct accaatagaa atatttgtaa tcaaagctat 540
ggtgtttcca gtagtcatgt atggatatga gaggtggacc ataaggaagg ctgagcag 598
<210> 15
<211> 611
<212> DNA
<213>Type-7 sequencing results
<400> 15
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggctgc gttccctgcc cggggtccca 120
gatctgccgg cgccacggtg ctgaccccgg gggacacaga gcgcgacgct gagtgtgggc 180
cctgcttgcc tgggtgagct ccgtgccgcc ctgcccacgt acccctcccg ggcatgggtc 240
ctgctgggag gagagtctca catctccagc tccgggagag gagggaagag gggcacaggt 300
ctcctggtgg gggtcccacc accttccacc cgcagggcag cccacctggg ctccatgtct 360
gtgtccctaa gtggacctca tcataatagc atctctgacc acccaaatca agcagatgtg 420
ttgaatactt aaaaggagac aacacatgtg gagtgaggaa agaaaaaaac aaggtatttt 480
ttgtattttt agtattctgg aaaaaaactg agggtgaaaa gctaccaata gaaatatttg 540
taatcaaagc tatggtgttt ccagtagtca tgtatggata tgagaggtgg accataagga 600
aggctgagca g 611
<210> 16
<211> 580
<212> DNA
<213>Type-8 sequencing results
<400> 16
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgaggg cttcttccgc gccacggtgc tgaccccggg 120
ggacacagag cgcgacgctg agtgtgggcc ctgcttgcct gggtgagctc cgtgccgccc 180
tgcccacgta cccctcccgg gcatgggtcc tgctgggagg agagtctcac atctccagct 240
ccgggagagg agggaagagg ggcacaggtc tcctggtggg ggtcccacca ccttccaccc 300
gcagggcagc ccacctgggc tccatgtctg tgtccctaag tggacctcat cataatagca 360
tctctgacca cccaaatcaa gcagatgtgt tgaatactta aaaggagaca acacatgtgg 420
agtgaggaaa gaaaaaaaca aggtattttt tgtattttta gtattctgga aaaaaactga 480
gggtgaaaag ctaccaatag aaatatttgt aatcaaagct atggtgtttc cagtagtcat 540
gtatggatat gagaggtgga ccataaggaa ggctgagcag 580
<210> 17
<211> 549
<212> DNA
<213>Type-9 sequencing results
<400> 17
gtggtggtcg tcgtggtgat gcagccgctg acccacctgt gtcccatcct tccctggcca 60
gtcctgcggt tatggcacca gggacgagga ctacggcgga gaagttctcc aagggcggcc 120
tgcttgcctg ggtgagctcc gtgccgccct gcccacgtac ccctcccggg catgggtcct 180
gctgggagga gagtctcaca tctccagctc cgggagagga gggaagaggg gcacaggtct 240
cctggtgggg gtcccaccac cttccacccg cagggcagcc cacctgggct ccatgtctgt 300
gtccctaagt ggacctcatc ataatagcat ctctgaccac ccaaatcaag cagatgtgtt 360
gaatacttaa aaggagacaa cacatgtgga gtgaggaaag aaaaaaacaa ggtatttttt 420
gtatttttag tattctggaa aaaaactgag ggtgaaaagc taccaataga aatatttgta 480
atcaaagcta tggtgtttcc agtagtcatg tatggatatg agaggtggac cataaggaag 540
gctgagcag 549
Claims (8)
- The method of the goat EDAR gene knockouts of 1.CRISPER-Cas9 System-mediateds, it is characterised in that it is according to goat EDAR gene orders, build two gRNA expression vectors based on CRISPER-Cas9 systems, then by after optimization Two gRNA expression vectors of CRISPER-Cas9 carriers and above-mentioned structure are transferred in the fetal fibroblast of goat jointly, are obtained Obtain the cell line of goat EDAR gene knockouts.
- 2. according to the method described in claim 1, it is characterised in that two gRNA expression vectors be respectively EDAR-gRNA1 and EDAR-gRNA2, and their action site is in opposite direction and is respectively positioned on 6 exons of sheep EDAR genes.
- 3. method according to claim 2, it is characterised in that sgRNA1 target sequences are 5 '- GGAGAACTTCTCCGCGGGGC-3 ', sgRNA2 target sequence are 5 '-CGGCGCCACAAGGACTGCGA -3 '.
- 4. the method according to claim any one of 1-3, it is characterised in that the goat includes Aerbasi Cashmere Goats '.
- 5. the method according to claim any one of 1-4, it is characterised in that the nucleotides of the CRISPER-Cas9 carriers Sequence such as SEQ ID NO:Shown in 1;The nucleotide sequence of the EDAR-gRNA1 expression vectors such as SEQ ID NO:Shown in 2;Institute State the nucleotide sequence such as SEQ ID NO of EDAR-gRNA2 expression vectors:Shown in 3.
- 6. the cell line of the goat EDAR gene knockouts obtained according to any one of claim 1-5 methods described.
- 7. according to application of any one of the claim 1-6 methods described in the cloned goat of production EDAR gene knockouts.
- 8. application according to claim 7, it is characterised in that with the thin of goat EDAR gene knockouts described in claim 6 Born of the same parents are nuclear transfer donor cell, and in vitro goat oocytes are nuclear transfer recipient cell, and sheep gram is obtained by nuclear transfer technology Then clone embryos are moved into goat entopic pregnancy by embryo transfer technology, obtain EDAR gene knockout goats by grand embryo.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710437991.3A CN106978445A (en) | 2017-06-12 | 2017-06-12 | The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710437991.3A CN106978445A (en) | 2017-06-12 | 2017-06-12 | The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106978445A true CN106978445A (en) | 2017-07-25 |
Family
ID=59344644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710437991.3A Pending CN106978445A (en) | 2017-06-12 | 2017-06-12 | The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106978445A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107435051A (en) * | 2017-07-28 | 2017-12-05 | 新乡医学院 | A kind of cell line gene knockout method that large fragment deletion is quickly obtained by CRISPR/Cas9 systems |
CN110172478A (en) * | 2019-06-11 | 2019-08-27 | 内蒙古大学 | The method of the goat KRTAP13-1 gene knockout of CRISPR/Cas9 System-mediated |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015121454A1 (en) * | 2014-02-14 | 2015-08-20 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
CN104928321A (en) * | 2015-02-12 | 2015-09-23 | 中国科学院西北高原生物研究所 | Crispr/Cas9-induced scale-missing zebra fish mode and establishment method |
CN105671080A (en) * | 2016-03-04 | 2016-06-15 | 内蒙古大学 | CRISPER-Cas9-system-mediated sheep MSTN (myostatin) gene knock-out and exogenous gene site-specific integration method |
CN106119283A (en) * | 2016-06-24 | 2016-11-16 | 广西壮族自治区水牛研究所 | A kind of method that the CRISPR of utilization Cas9 targeting knocks out MSTN gene |
-
2017
- 2017-06-12 CN CN201710437991.3A patent/CN106978445A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015121454A1 (en) * | 2014-02-14 | 2015-08-20 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
CN104928321A (en) * | 2015-02-12 | 2015-09-23 | 中国科学院西北高原生物研究所 | Crispr/Cas9-induced scale-missing zebra fish mode and establishment method |
CN105671080A (en) * | 2016-03-04 | 2016-06-15 | 内蒙古大学 | CRISPER-Cas9-system-mediated sheep MSTN (myostatin) gene knock-out and exogenous gene site-specific integration method |
CN106119283A (en) * | 2016-06-24 | 2016-11-16 | 广西壮族自治区水牛研究所 | A kind of method that the CRISPR of utilization Cas9 targeting knocks out MSTN gene |
Non-Patent Citations (2)
Title |
---|
FEI HAO ET AL.: ""Generation of Cashmere Goats Carrying an EDAR Gene Mutant Using CRISPR–Cas9-Mediated Genome Editing"", 《INT. J. BIOL. SCI.》 * |
郝斐: ""Edar基因敲除绒山羊胎儿成纤维细胞系的构建"", 《中国优秀硕士学位论文全文数据库 农业科技辑》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107435051A (en) * | 2017-07-28 | 2017-12-05 | 新乡医学院 | A kind of cell line gene knockout method that large fragment deletion is quickly obtained by CRISPR/Cas9 systems |
CN107435051B (en) * | 2017-07-28 | 2020-06-02 | 新乡医学院 | Cell line gene knockout method for rapidly obtaining large fragment deletion through CRISPR/Cas9 system |
CN110172478A (en) * | 2019-06-11 | 2019-08-27 | 内蒙古大学 | The method of the goat KRTAP13-1 gene knockout of CRISPR/Cas9 System-mediated |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107541525B (en) | Method for mediating goat Tbeta 4 gene fixed-point knock-in based on CRISPR/Cas9 technology | |
CN108570479B (en) | Method for mediating down producing goat VEGF gene fixed-point knock-in based on CRISPR/Cas9 technology | |
CN102146371B (en) | High glyphosate resistant variant gene and improvement method and application of high glyphosate resistant variant gene | |
CN107557393A (en) | Delivery system and its preparation method and application in a kind of CRISPR/Cas9 T cells of magnetic Nano material mediation | |
CN112852875B (en) | Construction method of CD3e transgenic mouse model for tracing tumor T lymphocyte infiltration | |
CN108949721A (en) | Express recombinant bacterial strain and the application of phospholipase D | |
CN111201317A (en) | Modified Cas9 protein and uses thereof | |
CN107893083A (en) | A kind of Human enterovirus virus D68 types infection clones and its construction method and application | |
CN112251464B (en) | Gene point mutation induction method | |
CN111748546B (en) | Fusion protein for generating gene point mutation and induction method of gene point mutation | |
CN106978445A (en) | The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds | |
CN112442515B (en) | Application of gRNA target combination in construction of hemophilia model pig cell line | |
CN101157935A (en) | Novel expression enzyme yeast gene engineering system | |
CN114317584B (en) | Construction system of novel transposon mutant strain library, novel transposon mutant library and application | |
CN106676135A (en) | Alb-uPA-teton lentiviral vector and preparation method and application thereof | |
CN111471635B (en) | Method for increasing content of nucleic acid in bacillus subtilis | |
CN111118049B (en) | Plasmid vector and application thereof | |
CN105567603B (en) | A method of Clostridium beijerinckii is improved to 4- hydroxycinnamic acid resistance | |
CN109880837B (en) | Method for degrading lignin in tobacco straw | |
CN109811008A (en) | The method of the mouse FGF5 gene knockout of CRISPR-Cas9 System-mediated | |
CN114107231A (en) | Recombinant adeno-associated virus for realizing cell body labeling of whole brain postsynaptic neurons and application thereof | |
CN112538497B (en) | CRISPR/Cas9 system and application thereof in construction of alpha, beta and alpha & beta thalassemia model pig cell lines | |
KR101443937B1 (en) | Method for production of TRACP5b | |
CN112625138A (en) | Multi-site recombinant antigen for detecting novel coronavirus and preparation method thereof | |
CN112522310B (en) | CRISPR system and application thereof in construction of LRP5 gene mutant osteoporosis clone pig nuclear donor cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170725 |
|
WD01 | Invention patent application deemed withdrawn after publication |